Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG-011 gel in adolescents and adults with mild-to-moderate atopic dermatitis
CTR20230499Phase 3Completed
- Sponsor
- Puqi Pharma
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pumecitinib in atopic dermatitis (AD), sponsored by Puqi Pharma. Started Mar 2023; status: completed.
02
Drugs
pumecitinib
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20230499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230499.